NEW YORK (GenomeWeb) – LifeCodexx of Constance, Germany, has started to transfer its noninvasive prenatal testing technology to several partner laboratories in Germany and Switzerland, the company said today.
The Center of Laboratory Medicine Dr. Risch in Bern, Switzerland, has been performing PrenaTest analyses for several months after offering the test to doctors in Switzerland and Liechtenstein through LifeCodexx since 2013. Swiss statutory health insurance decided to reimburse NIPT last year but said that the test analysis needs to be performed in Switzerland.
LifeCodexx has also transferred the PrenaTest technology to Labor Dr. Wisplinghoff in Cologne, which has been offering the test through LifeCodexx since 2013. In addition, the company plans to transfer the technology to Limbach Group in Ulm in the near future. The Medical Genetics Center (MGZ) in Munich will start performing PrenaTest analyses this spring and will provide the test to several other human genetic and prenatal diagnostic partners in the area.
The tech transfers are aided by LifeCodexx's PrenaBoxx NIPT data analysis solution, which runs locally and includes the company's CE-marked PrenaTest software. PrenaBoxx can analyze data from next-gen sequencing as well as from qPCR platforms.
According to LifeCodexx, more than 2,500 gynecologists in German-speaking countries already offer PrenaTest to their patients.